Changing The Landscape Of Cognitive Disease

Developing diagnostic advancements powered by research and technology excellence

The Future Of Diagnostics Is Now

Introducing Lucent Diagnostics, a commercial brand of Quanterix, created to deliver revolutionary tools that aid in the earlier detection of cognitive disease. Powered by ultra-sensitive SimoaTM technology, Lucent Diagnostics bridges the gap between research and clinical use by offering products and services designed specifically to meet the separate needs of institutions and healthcare providers. With more than a decade of proven success within the neurology research space, supported by thousands of publications and partnerships, Quanterix aims to directly impact the landscape of cognitive disease through its commercial brand, Lucent Diagnostics.


The information provided on this website is for educational purposes only and should not be considered as medical advice. Please consult with your healthcare provider for personalized guidance and treatment options.